Lab
Brookside Clinical Laboratory INC
Brookside Clinical Laboratory INC was paid $271K by Medicaid between Jan 2018 and Dec 2024, across 38 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 44% of everything it billed.
33Billing provider infoBROOKSIDE CLINICAL LABORATORY INC
ASTON, PA 19014
ASTON, PA 19014
33aNPI1629047436assigned 03/15/2006
33bProvider typeClinical Medical Laboratory
28Total paid$271K
24GClaims72,216
24DCodes billed38
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Pennsylvania
Rank by total paid#41 of 95
Median peer was paid$153K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 17,372 | $34K | |
| 2019 | 8,716 | $3K | |
| 2020 | 7,484 | $22K | |
| 2021 | 12,513 | $62K | |
| 2022 | 7,907 | $81K | |
| 2023 | 8,012 | $37K | |
| 2024incomplete | 10,212 | $31K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 44% | 4,220 | 1,887 | $119K |
| 80053 | Comprehensive metabolic panel | 8.4% | 4,325 | 3,414 | $23K |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 5.4% | 11,504 | 6,892 | $15K |
| 80048 | Basic metabolic panel (calcium, ionized) | 5.2% | 4,935 | 3,566 | $14K |
| 85027 | 5.1% | 4,661 | 3,457 | $14K | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | 4.5% | 3,373 | 1,499 | $12K |
| 84443 | Thyroid stimulating hormone (TSH) | 4.2% | 1,734 | 1,515 | $11K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.7% | 3,612 | 2,811 | $10K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.5% | 353 | 141 | $10K |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 2.7% | 5,825 | 3,310 | $7K |
| 80061 | Lipid panel | 2.4% | 1,460 | 1,374 | $6K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2.3% | 2,138 | 1,962 | $6K |
26 more codes
| 80164 | 1.8% | 345 | $5K | |
| 87088 | 1.2% | 1,443 | $3K | |
| 36415 | Collection of venous blood by venipuncture | 1.2% | 8,164 | $3K |
| 85610 | <1% | 1,200 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 249 | $2K |
| 87186 | <1% | 610 | $2K | |
| 87077 | <1% | 650 | $1K | |
| 81001 | <1% | 1,385 | $1K | |
| 80076 | <1% | 329 | $1K | |
| 84439 | <1% | 340 | $540.34 | |
| 99001 | <1% | 381 | $264.00 | |
| 80177 | <1% | 26 | $262.02 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,647 | $250.00 |
| 82565 | <1% | 43 | $203.83 | |
| 83735 | <1% | 73 | $123.31 | |
| 82607 | <1% | 16 | $62.48 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | <1% | 6,956 | $28.74 |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 0% | 25 | $0.00 |
| 87634 | 0% | 24 | $0.00 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 0% | 24 | $0.00 |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 24 | $0.00 |
| 87150 | 0% | 25 | $0.00 | |
| 87486 | 0% | 24 | $0.00 | |
| 87541 | 0% | 24 | $0.00 | |
| 87581 | 0% | 24 | $0.00 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 0% | 25 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialIACONO, JOHN (OWNER DIRECTOR)